enGenes Biotech GmbH | Biotech company
top of page
Image by CDC

Delivering cost-effective
Recombinant Proteins, Peptides & Plasmid DNA

enGenes Biotech delivers fast, efficient, and cost-effective solutions in molecular biology, protein expression, plasmid DNA production, and purification.
 
  • Best-in-class microbial process development
  • Record protein titers and secretion >10 g/L
  • Innovative solutions for scalable plasmid DNA & continuous manufacturing

Solution-oriented

Allows us to provide highly specialized and efficient services for protein and plasmid DNA production and purification in the most cost-effective manner.

Strong IPR position

Patented technology is critical to commercial success; enGenes Biotech's innovative solutions offer a competitive advantage to our clients in their respective markets.

Team of experts

With our team of experts who are committed to developing innovative and customized solutions that meet the unique needs and challenges of our clients.

 Arbeiten im Labor

About us

Our passion is your success

At enGenes Biotech GmbH, we believe that passion is the driving force behind our success, as it fuels our commitment to delivering innovative and customized solutions that exceed our clients' expectations. Without passion, we would not be able to overcome the challenges and complexities of the biotech industry and achieve our mission of advancing scientific research and development.

Nahaufnahme vom Pipettieren einer blauen Flüssigkeit

Technologies

Proprietary and patented technologies

are a distinct advantage to our clients, as they enable us to provide unique and innovative solutions that are not available elsewhere and give our clients a competitive edge in their respective markets.

Unique production platform

providing a reliable and cost-effective solution for the production of complex proteins for therapeutic and industrial applications.

Significant yield improvements

reducing costs and timelines for the production of biopharmaceuticals and industrial enzymes.

enGenes Newsroom

bottom of page